Enhancing Patient Adherence to Newly-Prescribed Medicine for Chronic Diseases: A Comprehensive Review and Cost-Effective Approach to Implementing the New Medicine Service in Community Pharmacies in Poland.

Autor: Merks P; Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University, Warsaw, Poland., Chełstowska B; Department of Biochemistry and Laboratory Diagnostics, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University, Warsaw, Poland., Religioni U; School of Public Health, Centre of Postgraduate Medical Education of Warsaw, Warsaw, Poland., Neumann-Podczaska A; Chair and Department of Palliative Medicine, Poznań University of Medical Sciences, Poznań, Poland., Krasiński Z; Department of Vascular and Endovascular Surgery, Angiology and Phlebology, Poznań University of Medical Sciences, Poznań, Poland., Kobayashi A; Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University, Warsaw, Poland., Plagens-Rotman K; Center for Sexology and Pediatric, Adolescent Gynecology, Division of Gynecology, Department of Perinatology and Gynecology, Poznań University of Medical Sciences, Poznań, Poland., Drelih E; The Polish Pharmacy Practice Research Network (PPPRN), Warsaw, Poland., Fehir-Sola K; European Association of Employed Community Pharmacists (EPhEU), Vienna, Austria., Fijałkowski Ł; Department of Organic Chemistry, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Bydgoszcz, Poland., Baj I; Gemini Pharmacies Poland, Gdańsk, Poland., Vaillancourt R; Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszyński University, Warsaw, Poland.; The Polish Pharmacy Practice Research Network (PPPRN), Warsaw, Poland., Wieczorowska-Tobis K; Chair and Department of Palliative Medicine, Poznań University of Medical Sciences, Poznań, Poland., Mastalerz-Migas A; Department of Family Medicine, Wrocław Medical University, Wrocław, Poland., Koziol M; Pharmacy Defence Association, Birmingham, United Kingdom., Pinkas J; School of Public Health, Centre of Postgraduate Medical Education of Warsaw, Warsaw, Poland., Szymański FM; Department of Civilization Diseases, Collegium Medicum, Cardinal Stefan Wyszyński University, Warsaw, Poland., Hering D; Department of Hypertension and Diabetology, Medical University of Gdańsk, Gdańsk, Poland.
Jazyk: angličtina
Zdroj: Medical science monitor : international medical journal of experimental and clinical research [Med Sci Monit] 2024 Mar 03; Vol. 30, pp. e942923. Date of Electronic Publication: 2024 Mar 03.
DOI: 10.12659/MSM.942923
Abstrakt: New Medicine Service (NMS) components are an important element to improve patient compliance with medical recommendations. NMS provides support to patients prescribed new medicines, helping them to manage long-term conditions. The purpose of this service is to provide patients with advice, guidelines, and educational materials regarding the use of new medicines to increase patient compliance and therapy safety. The NMS has already been introduced in many European countries. This review aims to identify the benefits and potential barriers to implementing the NMS in community pharmacies and to suggest solutions that would increase its effectiveness. Previous studies have primarily shown that the NMS improves patient compliance with therapy, accelerating the expected effects of the therapy. Pharmacist support during implementation of a new drug therapy substantially increases patient safety. As the experience of numerous countries shows, both pharmacists and patients express positive opinions on this service. Therefore, it seems that NMS should be an indispensable part of pharmaceutical patient care in any healthcare system. This article aims to review the implementation of the New Medicine Service (NMS) for community pharmacists in Poland and the provision of a cost-effective approach to improve patient adherence to newly-prescribed medicine for chronic diseases.
Databáze: MEDLINE